Kirkland Represents Bristol-Myers Squibb Company on Offering of $6B of Senior Notes

Kirkland & Ellis advised Bristol Myers Squibb (NYSE: BMY) on its public offering of senior unsecured notes in a combined aggregate principal amount of $6 billion and on its concurrent tender offer to purchase various series of its outstanding notes. The notes offering closed on March 2, 2022.

The Kirkland team was led by capital markets partners Sophia Hudson and Anne Peetz and associates Ieuan List, Logan Weissler, Colton Lyons and Ben Sharp.